MARIA A RODINO

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism WESTWOOD, NJ NPI 1497820906

General Payments — all program years on this page

$3,028.70

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 106
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $367.23 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $367.2316

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $180.625
Lilly USA, LLC $57.773
Amneal Pharmaceuticals LLC $47.533
ABBVIE INC. $34.352
Xeris Pharmaceuticals, Inc. $16.381
Insulet Corporation $15.441
IBSA Pharma Inc. $15.141

By program year

Program yearAmountRecords
2018 $1,476.7420
2019 $171.8114
2020 $214.8116
2021 $344.8624
2022 $176.176
2023 $277.0810
2024 $367.2316

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105963076 ABBVIE INC. $16.59 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105963078 ABBVIE INC. $17.76 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111690274 Amgen Inc. $17.91 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111690276 Amgen Inc. $15.57 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111690278 Amgen Inc. $124.98 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111690280 Amgen Inc. $10.96 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111690282 Amgen Inc. $11.20 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116805234 Insulet Corporation $15.44 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135146958 Lilly USA, LLC $22.57 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135153446 Lilly USA, LLC $16.98 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135165755 Lilly USA, LLC $18.22 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139199868 Amneal Pharmaceuticals LLC $16.19 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139199870 Amneal Pharmaceuticals LLC $15.86 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139199872 Amneal Pharmaceuticals LLC $15.48 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142979851 IBSA Pharma Inc. $15.14 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144604282 Xeris Pharmaceuticals, Inc. $16.38 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.